Sandhill Capital Partners LLC Athenex, Inc. Call Options Transaction History
Sandhill Capital Partners LLC
- $1.35 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ATNX
# of Institutions
3Shares Held
1.46MCall Options Held
0Put Options Held
0About Athenex, Inc.
- Ticker ATNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 156,790,000
- Market Cap $1.57M
- Description
- Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...